Door-Through-Door Companion Rideshare Technology for Individuals With Alzheimer's Disease and Related Dementias (AD/ADRD)

Summary

The goal of this pilot randomized controlled trial is to assess the impact of D2D rideshare services with a trained companion driver on the rate of medical appointments for older adults and individuals with AD/ADRD. Participants will be assigned either door-through-door (D2D) rideshare or curb-to-curb (C2C) rideshare services. he main question it aims to answer is: Do D2D rideshare services reduce missed medical appointment rates compared to C2C rideshare services?

Eligibility

Inclusion Criteria:

* All participants (or their surrogate) have the capacity to agree to allow Onward service for transportation;
* have scheduled medical appointments at partner practices of Onward;
* ages 60+
* community-dwelling;
* 60 participants who self-reported cognitive problems, such as memory issue, or have mild cognitive impairment, subjective cognitive decline, or AD/ADRD diagnosis
* Resides and attends appointments in the following San Francisco Bay Area Counties (San Francisco, Alameda, Contra Costa, Marin, San Mateo, Sonoma)

Exclusion Criteria:

* current enrollment in another transportation study;
* already using any type of free or heavily subsized transportation service;
* enrollees with comfort care only;
* Not wheelchair bound, e.g. if using a wheelchair must be foldable and must be able to transfer
* Transient, lacking consistent long term housing
* Resides outside of the San Francisco Bay Area

Conditions4

Locations1 site

Browse More Trials